201 related articles for article (PubMed ID: 12777394)
1. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance.
Most P; Remppis A; Pleger ST; Löffler E; Ehlermann P; Bernotat J; Kleuss C; Heierhorst J; Ruiz P; Witt H; Karczewski P; Mao L; Rockman HA; Duncan SJ; Katus HA; Koch WJ
J Biol Chem; 2003 Sep; 278(36):33809-17. PubMed ID: 12777394
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein.
Gusev K; Ackermann GE; Heizmann CW; Niggli E
Gen Physiol Biophys; 2009 Dec; 28(4):371-83. PubMed ID: 20097960
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
4. S100A1: a regulator of myocardial contractility.
Most P; Bernotat J; Ehlermann P; Pleger ST; Reppel M; Börries M; Niroomand F; Pieske B; Janssen PM; Eschenhagen T; Karczewski P; Smith GL; Koch WJ; Katus HA; Remppis A
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13889-94. PubMed ID: 11717446
[TBL] [Abstract][Full Text] [Related]
5. The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes.
Remppis A; Most P; Löffler E; Ehlermann P; Bernotat J; Pleger S; Börries M; Reppel M; Fischer J; Koch WJ; Smith G; Katus HA
Basic Res Cardiol; 2002; 97 Suppl 1():I56-62. PubMed ID: 12479236
[TBL] [Abstract][Full Text] [Related]
6. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.
Most P; Pleger ST; Völkers M; Heidt B; Boerries M; Weichenhan D; Löffler E; Janssen PM; Eckhart AD; Martini J; Williams ML; Katus HA; Remppis A; Koch WJ
J Clin Invest; 2004 Dec; 114(11):1550-63. PubMed ID: 15578088
[TBL] [Abstract][Full Text] [Related]
7. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
8. The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibers.
Most P; Remppis A; Weber C; Bernotat J; Ehlermann P; Pleger ST; Kirsch W; Weber M; Uttenweiler D; Smith GL; Katus HA; Fink RH
J Biol Chem; 2003 Jul; 278(29):26356-64. PubMed ID: 12721284
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
[TBL] [Abstract][Full Text] [Related]
10. Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein.
Zhu M; Gach AA; Liu G; Xu X; Lim CC; Zhang JX; Mao L; Chuprun K; Koch WJ; Liao R; Koren G; Blaxall BC; Mende U
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1335-47. PubMed ID: 18192223
[TBL] [Abstract][Full Text] [Related]
11. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P
Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
[TBL] [Abstract][Full Text] [Related]
12. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice.
Du XJ; Cole TJ; Tenis N; Gao XM; Köntgen F; Kemp BE; Heierhorst J
Mol Cell Biol; 2002 Apr; 22(8):2821-9. PubMed ID: 11909974
[TBL] [Abstract][Full Text] [Related]
13. S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.
Ritterhoff J; Völkers M; Seitz A; Spaich K; Gao E; Peppel K; Pleger ST; Zimmermann WH; Friedrich O; Fink RHA; Koch WJ; Katus HA; Most P
Mol Ther; 2015 Aug; 23(8):1320-1330. PubMed ID: 26005840
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation.
He H; Giordano FJ; Hilal-Dandan R; Choi DJ; Rockman HA; McDonough PM; Bluhm WF; Meyer M; Sayen MR; Swanson E; Dillmann WH
J Clin Invest; 1997 Jul; 100(2):380-9. PubMed ID: 9218515
[TBL] [Abstract][Full Text] [Related]
15. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
[TBL] [Abstract][Full Text] [Related]
16. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts.
Remppis A; Pleger ST; Most P; Lindenkamp J; Ehlermann P; Schweda C; Löffler E; Weichenhan D; Zimmermann W; Eschenhagen T; Koch WJ; Katus HA
J Gene Med; 2004 Apr; 6(4):387-94. PubMed ID: 15079813
[TBL] [Abstract][Full Text] [Related]
17. Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes.
Most P; Boerries M; Eicher C; Schweda C; Völkers M; Wedel T; Söllner S; Katus HA; Remppis A; Aebi U; Koch WJ; Schoenenberger CA
J Cell Sci; 2005 Jan; 118(Pt 2):421-31. PubMed ID: 15654019
[TBL] [Abstract][Full Text] [Related]
18. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity.
Tang M; Zhang X; Li Y; Guan Y; Ai X; Szeto C; Nakayama H; Zhang H; Ge S; Molkentin JD; Houser SR; Chen X
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H519-28. PubMed ID: 20543081
[TBL] [Abstract][Full Text] [Related]
19. S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling.
Prosser BL; Wright NT; Hernãndez-Ochoa EO; Varney KM; Liu Y; Olojo RO; Zimmer DB; Weber DJ; Schneider MF
J Biol Chem; 2008 Feb; 283(8):5046-57. PubMed ID: 18089560
[TBL] [Abstract][Full Text] [Related]
20. S100A1 in human heart failure: lack of recovery following left ventricular assist device support.
Bennett MK; Sweet WE; Baicker-McKee S; Looney E; Karohl K; Mountis M; Tang WH; Starling RC; Moravec CS
Circ Heart Fail; 2014 Jul; 7(4):612-8. PubMed ID: 24842913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
